GLP-1 weight loss drugs reduce food spending, creating a $6.5 billion challenge for major grocery retailers
By
Daniel Kline
The bagel they save for the regulars. Don't skim, savour.
Summary
The article discusses how GLP-1 weight loss drugs like tirzepatide are significantly impacting consumer spending on food, creating a $6.5 billion problem for major grocery retailers like Kroger, Walmart, and Costco. Users of these medications eat less, buy less food, and waste more leftovers, leading to reduced grocery sales. The piece combines personal experience with analysis of the economic ripple effects on the food retail industry.
Key quotes
· 4 pulledTaking the drug, which I administer as a shot once a week, has lessened my appetite, but not my desire to eat.
For the first few months, it did not really change my grocery shopping habits because my brain still wanted to eat like it used to.
Over time, and having thrown away a lot of leftovers, I have been purchasing less food and cooking smaller meals.
At restaurants, I used to routinely order an appetizer and a meal, and now I often get one or the other.
You might also wanna read
Study: Ozempic and Wegovy Reduce Household Food Spending and Change Purchasing Patterns
New research published in the Journal of Marketing Research shows that GLP-1 receptor agonist drugs like Ozempic and Wegovy are significantl
news.cornell.edu·4mo ago
Study: Most Patients Regain Weight and Lose Health Benefits After Stopping GLP-1 Drugs
A study on tirzepatide (a GLP-1 drug) found that after stopping the medication, 82% of participants regained at least 25% of the weight they
arstechnica.com·6mo ago
What Happens When You Stop Taking GLP-1 Weight Loss Medications
This article examines the experiences of people who stop taking GLP-1 weight loss medications (like Ozempic and Wegovy), exploring what happ
bbc.com·5mo ago
Study: Stopping GLP-1 Drugs Increases Heart Attack and Stroke Risk
New research published in BMJ Medicine reveals that stopping GLP-1 drugs (originally for diabetes, now popular for weight loss) leads to a r
nautil.us·2mo ago
Novo Nordisk launches first GLP-1 weight loss pill Wegovy in US at lower price than injections
Novo Nordisk has launched the first pill version of its blockbuster GLP-1 weight loss drug Wegovy in the US at a significantly lower price t
theguardian.com·4mo ago